WebApr 13, 2024 · CSL’s continued innovation has been core to their enviable track record of double-digit earnings growth – with a long R&D pipeline and various products in phase 3 … Web1 day ago · Financial Performance. In 2024, CSL's revenue was $6.59 billion, an increase of 37.04% compared to the previous year's $4.81 billion. Earnings were $924.00 million, an increase of 119.11%.
Carlisle (CSL) Q3 Earnings & Sales Top Estimates, Rise Y/Y - Yahoo …
WebFeb 17, 2024 · CSL Earnings Insights. Looking ahead, revenue is forecast to grow 10% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Biotechs industry in Australia. WebCSL's 2024 Half Year Financial Results - Announcement Information. We have announced our 2024 Half Year Results for the period ending 31st December 2024. Announcement Information and Webcast Recording were released on Tuesday, 14th February 2024 … earthquake terror by peg kehret ar anwsers
Carlisle Companies Incorporated (CSL) - Stock Analysis
WebMar 29, 2024 · Carlisle Companies. (CSL) is scheduled to report earnings on April 27, 2024.The last reported earnings were for reported on February 7, 2024 for Q4. WebApr 14, 2024 · Carlisle Companies (NYSE:CSL - Get Rating) last announced its earnings results on Tuesday, February 7th. The conglomerate reported $3.92 earnings per share for the quarter, beating the consensus estimate of $3.86 by $0.06. The business had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.44 billion. WebAug 18, 2024 · CSL Limited (OTCPK:CSLLY) Q4 2024 Earnings Conference Call August 17, 2024 8:00 PM ETCompany ParticipantsMark Dehring - Vice President, Investor RelationsPaul Perreault - Chief Executive... ct neck icd 9